FIELD: medicine, oncology. SUBSTANCE: it is suggested to conduct either before and/or after neurosurgical interference immunotherapy dealing with intravenous injection of lymphakine-activated killer cells isolated from 800 ml patient's venous blood with 2 mln. IU yeast recombinant interleukin-2. The present method enables to provide easy surgical removal of tumor at no pronounced side effects. EFFECT: higher efficiency of therapy. 1 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING INTRACEREBRAL TUMOR OF THE BRAIN | 1997 |
|
RU2133624C1 |
| METHOD OF DIAGNOSTICS OF INDUCED IMMUNE INFLAMMATION FOCUS IN BRAIN | 1997 |
|
RU2124861C1 |
| METHOD FOR IMMUNOTHERAPY OF CEREBRAL MALIGNANT TUMORS | 2004 |
|
RU2262941C2 |
| METHOD FOR TREATING MALIGNANT BRAIN TUMORS | 2000 |
|
RU2192263C2 |
| METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2175242C1 |
| METHOD OF IMMUNOTHERAPY MALIGNANT TUMORS OF BRAIN | 2018 |
|
RU2686756C1 |
| METHOD OF ADJUVANT IMMUNOTHERAPY OF PRIMARY AND METASTATIC MALIGNANT UNRESECTABLE LIVER TUMOURS | 2006 |
|
RU2326601C2 |
| METHOD FOR APPLYING COMBINED IMMUNOTHERAPY OF MALIGNANT BRAIN TUMORS | 2000 |
|
RU2197985C2 |
| NEUROSURGICAL METHOD FOR TREATING THE CASES OF INFANTINE CEREBRAL PARALYSIS | 2001 |
|
RU2185106C1 |
| METHOD OF TREATING ONCOLOGICAL PATIENTS WITH CYTOTOXIC LYMPHOCYTES | 2015 |
|
RU2596505C1 |
